vs

Side-by-side financial comparison of CITIUS ONCOLOGY, INC. (CTOR) and High Roller Technologies, Inc. (ROLR). Click either name above to swap in a different company.

High Roller Technologies, Inc. is the larger business by last-quarter revenue ($6.3M vs $3.9M, roughly 1.6× CITIUS ONCOLOGY, INC.). High Roller Technologies, Inc. runs the higher net margin — 58.4% vs -140.3%, a 198.7% gap on every dollar of revenue.

Citius Oncology, Inc. is a late-stage biopharmaceutical company focused on developing innovative targeted therapies for cancer patients. Its core pipeline covers treatments addressing unmet medical needs in hematologic malignancies and solid tumors, primarily serving North American and global oncology care markets.

S&S – Sansei Technologies is an American company known for its pneumatically powered amusement rides and roller coaster designing.

CTOR vs ROLR — Head-to-Head

Bigger by revenue
ROLR
ROLR
1.6× larger
ROLR
$6.3M
$3.9M
CTOR
Higher net margin
ROLR
ROLR
198.7% more per $
ROLR
58.4%
-140.3%
CTOR

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CTOR
CTOR
ROLR
ROLR
Revenue
$3.9M
$6.3M
Net Profit
$-5.5M
$3.7M
Gross Margin
80.0%
Operating Margin
-133.2%
1.3%
Net Margin
-140.3%
58.4%
Revenue YoY
-16.4%
Net Profit YoY
16.9%
831.9%
EPS (diluted)
$-0.06
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTOR
CTOR
ROLR
ROLR
Q4 25
$3.9M
Q3 25
$6.3M
Q2 25
$6.9M
Q1 25
$6.8M
Q3 24
$7.5M
Net Profit
CTOR
CTOR
ROLR
ROLR
Q4 25
$-5.5M
Q3 25
$3.7M
Q2 25
$-592.0K
Q1 25
$-3.3M
Q3 24
$-501.0K
Gross Margin
CTOR
CTOR
ROLR
ROLR
Q4 25
80.0%
Q3 25
Q2 25
Q1 25
Q3 24
Operating Margin
CTOR
CTOR
ROLR
ROLR
Q4 25
-133.2%
Q3 25
1.3%
Q2 25
-7.2%
Q1 25
-47.4%
Q3 24
-6.3%
Net Margin
CTOR
CTOR
ROLR
ROLR
Q4 25
-140.3%
Q3 25
58.4%
Q2 25
-8.5%
Q1 25
-48.4%
Q3 24
-6.7%
EPS (diluted)
CTOR
CTOR
ROLR
ROLR
Q4 25
$-0.06
Q3 25
$0.39
Q2 25
$-0.07
Q1 25
$-0.39
Q3 24
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTOR
CTOR
ROLR
ROLR
Cash + ST InvestmentsLiquidity on hand
$7.3M
$2.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$58.4M
$6.6M
Total Assets
$110.0M
$16.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTOR
CTOR
ROLR
ROLR
Q4 25
$7.3M
Q3 25
$2.7M
Q2 25
$2.7M
Q1 25
$3.5M
Q3 24
$1.3M
Stockholders' Equity
CTOR
CTOR
ROLR
ROLR
Q4 25
$58.4M
Q3 25
$6.6M
Q2 25
$2.6M
Q1 25
$2.8M
Q3 24
$-779.0K
Total Assets
CTOR
CTOR
ROLR
ROLR
Q4 25
$110.0M
Q3 25
$16.0M
Q2 25
$12.3M
Q1 25
$12.8M
Q3 24
$12.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTOR
CTOR
ROLR
ROLR
Operating Cash FlowLast quarter
$-7.4M
$-78.0K
Free Cash FlowOCF − Capex
$-90.0K
FCF MarginFCF / Revenue
-1.4%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
-0.02×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTOR
CTOR
ROLR
ROLR
Q4 25
$-7.4M
Q3 25
$-78.0K
Q2 25
$-840.0K
Q1 25
$-3.6M
Q3 24
Free Cash Flow
CTOR
CTOR
ROLR
ROLR
Q4 25
Q3 25
$-90.0K
Q2 25
$-845.0K
Q1 25
$-3.6M
Q3 24
FCF Margin
CTOR
CTOR
ROLR
ROLR
Q4 25
Q3 25
-1.4%
Q2 25
-12.2%
Q1 25
-53.5%
Q3 24
Capex Intensity
CTOR
CTOR
ROLR
ROLR
Q4 25
Q3 25
0.2%
Q2 25
0.1%
Q1 25
0.2%
Q3 24
Cash Conversion
CTOR
CTOR
ROLR
ROLR
Q4 25
Q3 25
-0.02×
Q2 25
Q1 25
Q3 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTOR
CTOR

Segment breakdown not available.

ROLR
ROLR

Net Gaming Revenue$4.9M77%
Net Revenue Noncore Services$1.4M23%

Related Comparisons